Attached files
| file | filename |
|---|---|
| EX-3.1.1 - CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION DATED DECEMBER 12, 201 - Modern Mobility Aids, Inc. | exhibit_3-1.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of
Report (Date of earliest event reported)
GALILEO LIFE SCIENCES,
INC.
(Exact
name of registrant as specified in its charter)
|
Nevada
|
333-168983
|
27-4677038
|
|
(State
or other jurisdiction of incorporation)
|
(Commission File
Number)
|
(IRS
Employer Identification No.)
|
|
First Canadian Place
Suite 350
Toronto, Ontario
Canda
|
|
M5X 1C1
|
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
(416) 890 4820
Registrant’s
telephone number, including area code
N/A
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
|
☒
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
|
☒
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
__________
1
SECTION 5. CORPORATE GOVERNANCE AND MANAGEMENT
ITEM 5.03 AMENDMENT TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGES
IN FISCAL YEAR
Effective December 12, 2014, the Board of Directors of then Modern
Mobility Aids, Inc., a Nevada corporation (the
“Company”), pursuant to unanimous written consent board
of director resolutions, authorized a change in the
Company’s name to Galileo Life Sciences, Inc. (the
“Name Change”). On December 12, 2014, the Company filed
a Certificate of Amendment with the Nevada Secretary of State
amending its articles of incorporation to reflect the change in
corporate name to “Galileo Life Sciences Inc.” (the
“Amendment). The Amendment was approved by the Board of
Directors pursuant to written consent resolutions dated December
12, 2014 and further approved by the shareholders holding a
majority of the total issued and outstanding shares of common stock
of the Company pursuant to written consent resolutions dated
December 12, 2014.
SECTION 9 – FINANCIAL STATEMENTS AND EXHIBITS
Item
9.01
Financial
Statements and Exhibits
(a) Financial Statements of Business Acquired.
Not
applicable.
(b) Pro forma Financial Information.
Not
applicable.
(c) Shell Company Transaction.
Not
applicable.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned hereunto duly
authorized.
|
|
GALILEO LIFE SCIENCES INC. a/k/a/ MODERN MOBILITY AIDS,
INC.
|
|
|
/s/
Tito DiMarco
|
|
DATE: September 29, 2017
|
Name: Tito DiMarco
Title: President/Chief Executive Officer
|
__________
2